AD-41-WB70_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, {5-[2-(2,6-Dichloro-phenyl)-3H-benzoimidazol-5-yl]-[1,3,4]oxadiazol-2-yl}-(6-methyl-pyridin-3-yl)-amine, Diacylglycerol Acyltransferase type 1 (DGAT-1) Inhibitors targeting DGAT1 (Novartis, 25235948)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/25235948
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the AD-41-WB70_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value

decreased expression

Symbol Name Standardized Value
RPL11 ribosomal protein L11 -3.56866
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -2.41175
LRRC37B leucine rich repeat containing 37B -1.72333
RXYLT1 ribitol xylosyltransferase 1 -1.37388
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle -1.03781
RPS14 ribosomal protein S14 -0.744189
RBPJ recombination signal binding protein for immunoglobulin kappa J region -0.698244
HRNR hornerin -0.550139
SAV1 salvador family WW domain containing protein 1 -0.3368
SPG21 spastic paraplegia 21 (autosomal recessive, Mast syndrome) -0.335852
CMTM3 CKLF-like MARVEL transmembrane domain containing 3 -0.224204